Hostname: page-component-77c89778f8-m8s7h Total loading time: 0 Render date: 2024-07-17T09:47:24.371Z Has data issue: false hasContentIssue false
  • English
  • Français

The Inventory of Psychotic-Like Anomalous Self-Experiences (IPASE): an easy tool for investigating Self-Disorders, subjective experiences and global functioning

Published online by Cambridge University Press:  19 July 2023

F. Magnani ,
S. Amorosi ,
C. Dell’Anna ,
V. Lucarini ,
M. Ballerini ,
C. Marchesi  and
M. Tonna
F. Magnani*
Affiliation:
1Department of Medicine and Surgery, Unit of Neuroscience, Parma University Hospital, Parma, Italy
S. Amorosi
Affiliation:
1Department of Medicine and Surgery, Unit of Neuroscience, Parma University Hospital, Parma, Italy
C. Dell’Anna
Affiliation:
1Department of Medicine and Surgery, Unit of Neuroscience, Parma University Hospital, Parma, Italy
V. Lucarini
Affiliation:
2Institute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, Paris, France
M. Ballerini
Affiliation:
3Department of Mental Health, Local Health Service, Firenze
C. Marchesi
Affiliation:
1Department of Medicine and Surgery, Unit of Neuroscience, Parma University Hospital, Parma, Italy 4Department of Mental Health, Local Health Service, Parma, Italy
M. Tonna
Affiliation:
1Department of Medicine and Surgery, Unit of Neuroscience, Parma University Hospital, Parma, Italy 4Department of Mental Health, Local Health Service, Parma, Italy
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Self Disorders (SDs) are regarded as the subjective phenotype of Schizophrenia vulnerability. The EASE (Examination of Anomalous Self-Experiences) scale is the most detailed and widely used instrument to investigate SDs, but it requires long administration times and specific training. The IPASE (Inventory of Psychotic-like Anomalous Self-Experiences) scale might be a self-administered instrument of widespread use for an easier SDs investigation.

Objectives

The present study was aimed at validating the Italian version of IPASE, testing its internal consistency and usability for a first level SDs survey. A secondary objective was to confirm the correlations between IPASE, EASE, main symptom dimensions, subjective bodily experiences, symptoms of schizophrenic autism as well as levels of global functioning.

Methods

Fifty patients with Schizophrenia were administered the IPASE scale in its Italian version, the Examination of Anomalous Self-Experiences scale (EASE), the Positive And Negative Symptoms Scale (PANSS), the Social and Occupational Functioning Assessment Scale (SOFAS) to assess global functioning, the Autism Rating Scale (ARS) and the Abnormal Bodily Phenomena questionnaire (ABPq). The internal consistency of IPASE in its Italian version was investigated and the correlations between IPASE, EASE, ABP, ARS, PANSS and SOFAS were explored.

Results

The internal consistency of the Italian version of IPASE was high (α 0.97). The IPASE and EASE total scores were positively correlated with each other, as were many of the conceptually related subdomains of both scales. The IPASE score was negatively correlated with global functioning (SOFAS) and positively correlated with total PANSS scores and with PANSS negative domain. Moreover, the IPASE total score was positively correlated with autism dimension (ARS), while anomalies in subjective experience of the lived body were coherently correlated with higher scores in IPASE “somatization” subdomain.

Conclusions

The IPASE may be an easy instrument with high internal consistency for an initial investigation of SDs. IPASE domains appear to be correlated with the SDs investigated through EASE and with the main symptomatologic dimensions of Schizophrenia, in particular with negative symptoms. IPASE might also be a useful instrument for a first level investigation of subjective experiences concerning intersubjectivity and bodily dimensions.

SDs are confirmed to be a core feature of the schizophrenia psychopathology, with a adverse impact on global functioning.

Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 66 , Special Issue S1: Abstracts of the 31st European Congress of Psychiatry , March 2023 , pp. S262
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.